Concepedia

Lingxi Kong

LK

Statistics

Publications

7

Citations

539

H-Index

7

Active since

2012

Affiliations

Chongqing Medical University(Current)

The Affiliated Yongchuan Hospital of Chongqing Medical University

Lingxi Kong is an author at Chongqing Medical University specializing in medicine, pharmacology, and molecular pharmacology.

Publications per year

2012–2023

7

Publications

7

Kaempferol alleviates insulin resistance via hepatic IKK/NF-κB signal in type 2 diabetic rats

Cheng Luo, Hui Yang, Chengyong Tang et al. · International Immunopharmacology · 2015 · 166 citations

, , +14

The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits

Lingxi Kong, Cheng Luo, Xiuying Li et al. · Lipids in Health and Disease · 2013 · 131 citations · Full text

, , +17

COVID-19 Myocarditis and Severity Factors: An Adult Cohort Study

Kunlong Ma, Zhi‐Heng Liu, Chun-Feng Cao et al. · medRxiv · 2020 · 73 citations · Full text

, , +14

Kaempferol suppresses lipid accumulation in macrophages through the downregulation of cluster of differentiation 36 and the upregulation of scavenger receptor class B type I and ATP-binding cassette transporters A1 and G1

Xiuying Li, Lingxi Kong, Juan Li et al. · International Journal of Molecular Medicine · 2012 · 65 citations · Full text

, , +17

Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study

Huaping Chen, Siyuan Chen, Shan Li et al. · Oncotarget · 2017 · 43 citations · Full text

, , +17

1–5 of 7